Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis: Monitoring Efficacy of Ongoing Treatment Programs in Papua New Guinea

NCT03268252 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.

NCT NCT03268252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03268252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis: Monitoring Efficacy of Ongoing Treatment Programs in Papua New Guinea
Lead sponsor
University Hospitals Cleveland Medical Center
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
December 31, 2018
Enrollment
3,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic filariasis